GlassScriptPhysician profile
David L Weinstein
NPI 1043328305
$9,551.49
in general payments reported to CMS, 2019-2025
53 companies · $635 in 2025
The $635 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $773 · 2020: $1,638 · 2021: $1,896 · 2022: $1,821 · 2023: $1,778 · 2024: $1,011 · 2025: $635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,423.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,011.49 | 2019-2025 | Liletta, Ubrelvy, Lo Loestrin Fe |
| Amgen INC. | $991.87 | 2019-2025 | Evenity, Prolia, Prolia |
| Coopersurgical, INC. | $769.80 | 2019-2024 | Paragard T 380a, Paragard T 380a, Fisherbrand Disposable Liquid Infant Heel Warmer |
| Genbiopro, INC. | $500.00 | 2020 | |
| Mayne Pharma Commercial LLC | $482.41 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $358.46 | 2023-2025 | Myfembree, Gemtesa |
| Evofem Biosciences, INC. | $338.76 | 2021-2025 | Phexxi, Solosec, Phexx |
| Organon LLC | $288.37 | 2021-2025 | Nexplanon, Jada System |
| Pfizer INC. | $279.72 | 2019-2025 | |
| Novo Nordisk INC | $234.14 | 2019-2021 | |
| Meditrina | $224.96 | 2021-2023 | |
| Millicent US INC | $224.17 | 2024-2025 | Femlyv, Intrarosa |
| Hologic Sales and Service, LLC | $223.10 | 2019-2025 | Thinprep 2000 Processor, Aptima, Third Wave |
| Astellas Pharma US INC | $221.43 | 2019-2025 | Veozah, Myrbetriq |
| Agile Therapeutics, INC. | $186.01 | 2021-2023 | Twirla |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.